CGEM
CGEM
US2300311063
Cullinan Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
999.43M EUR
1.17B EUR
873.22M EUR
Enterprise Value
662.46M EUR
1.1B EUR
800.53M EUR
Valuation Multiples
Trailing P/E
--
--
--
Forward P/E
-5.65x
--
--
Price to Sales
--
--
--
Price to Book
3.11x
3.64x
2.38x
EV/Revenue
--
--
--
EV/EBITDA
-2.99x
--
--
Price to FCF (P/FCF)
--
--
--
EV/FCF
--
--
--
FCF Yield
-8.93%
-13.6%
-20.46%
ende